Home >> CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets, Volume 5, Number 3
CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets logo Bentham Science Publishers logo

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in neurological and CNS disorders. As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

Click here to see all previous issues.

Publisher: Bentham Science Publishers

Related content
Volume 5, Number 3, June 2006

< previous issue | all issues | next issue >

Articles

G Protein-Coupled Receptors in Regulation of Body Weight
pp. 241-249(9)
Author: Schioth, Helgi B.

Melanocortin Receptors as Drug Targets for Disorders of Energy Balance
pp. 251-261(11)
Authors: Adan, Roger A.H.; Dijk, Gertjan v.

NPY Receptors as Drug Targets for the Central Regulation of Body Weight
pp. 263-274(12)
Authors: Feletou, Michel; Galizzi, Jean-Pierre; Levens, Nigel R.

Endocannabinoids in Appetite Control and the Treatment of Obesity
pp. 275-292(18)
Authors: Kirkham, T. C.; Tucci, S. A.

Monoamine Receptors in the Regulation of Feeding Behaviour and Energy Balance
pp. 293-312(20)
Authors: Clifton, P. G.; Kennett, G. A.

Roles of Orexins and Orexin Receptors in Central Regulation of Feeding Behavior and Energy Homeostasis
pp. 313-325(13)
Author: Sakurai, Takeshi

Galanin/GALP Receptors and CNS Homeostatic Processes
pp. 327-334(8)
Authors: Robinson, J. K.; Bartfai, T.; Langel, U.

Growth Hormone Secretagogue (Ghrelin-) Receptors - A Complex Drug Target for the Regulation of Body Weight
pp. 335-343(9)
Authors: Nogueiras, R.; Perez-Tilve, D.; Wortley, K. E.; Tschop, M.

D1 and Functionally Selective Dopamine Agonists as Neuroprotective Agents in Parkinson's Disease
pp. 345-353(9)
Authors: Lewis, M. M.; Huang, X.; Nichols, D. E.; Mailman, R. B.

Signaling Mechanisms Underlying Aβ Toxicity: Potential Therapeutic Targets for Alzheimer's Disease
pp. 355-361(7)
Authors: Smith, Wanli W.; Gorospe, Myriam; Kusiak, John W.

The Vitamin D Neuroendocrine System as a Target for Novel Neurotropic Drugs
pp. 363-371(9)
Authors: Kalueff, A. V.; Minasyan, A.; Keisala, T.; Kuuslahti, M.; Miettinen, S.; Tuohimaa, P.

< previous issue | all issues | next issue >

Marked list

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
^ Back to top
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page